Shopping Cart
- Remove All
- Your shopping cart is currently empty
GV-196771A A novel NMDA receptor glycine site antagonist with potent antinociceptive activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $700 | 6-8 weeks | |
5 mg | $1,800 | 6-8 weeks |
Description | GV-196771A A novel NMDA receptor glycine site antagonist with potent antinociceptive activity. |
In vivo | GV196771A, developed for the treatment of neuropathic pain, is a potent antagonist of the modulatory glycine site of the N-methyl-D-aspartate receptor (NMDA receptor). It exhibits low oral bioavailability in rats and mice, with a bioavailability of less than 10% and a plasma clearance of approximately 2 mL/min/kg[1]. |
Molecular Weight | 423.23 |
Formula | C20H13Cl2N2NaO3 |
Cas No. | 166974-23-8 |
Smiles | [O-]C(C1=C(C2=C(Cl)C=C(Cl)C=C2N1)/C=C3C(N(C4=CC=CC=C4)CC/3)=O)=O.[Na+] |
Relative Density. | no data available |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.